I. Zavaroni

发表

Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome.

P. Nilsson, B. Balkau, B. Hedblad, 2002, Diabetes & metabolism.

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance.

E. Bonora, G. Reaven, M. Passeri, 1989, The New England journal of medicine.

Characterization of Three Kindreds With Familial Combined Hypolipidemia Caused by Loss-of-Function Mutations of ANGPTL3

G. Franceschini, D. Ardigò, E. Favari, 2012, Circulation. Cardiovascular genetics.

Intervention study with a high or low antioxidant capacity diet: effects on circulating β-carotene

N. Pellegrini, D. Ardigò, L. Monti, 2009, European Journal of Clinical Nutrition.

The total antioxidant capacity of the diet is an independent predictor of plasma β-carotene

N. Pellegrini, D. Ardigò, P. Riso, 2007, European Journal of Clinical Nutrition.

Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects.

N. Pellegrini, D. Ardigò, M. Serafini, 2005, The British journal of nutrition.

Intake of the plant lignans matairesinol, secoisolariciresinol, pinoresinol, and lariciresinol in relation to vascular inflammation and endothelial dysfunction in middle age-elderly men and post-menopausal women living in Northern Italy.

N. Pellegrini, D. Ardigò, F. Brighenti, 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Feasibility and Effectiveness in Clinical Practice of a Multifactorial Intervention for the Reduction of Cardiovascular Risk in Patients With Type 2 Diabetes

M. Boemi, D. Ardigò, M. Trovati, 2013, Diabetes Care.

Feasibility and Effectiveness in Clinical Practice of a Multifactorial Intervention for the Reduction of Cardiovascular Risk in Patients With Type 2 Diabetes The 2-year interim analysis of the MIND . IT study : a cluster randomized trial

M. Boemi, D. Ardigò, M. Trovati, 2013 .

Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects

A. Pezzarossa, E. Bonora, E. Dall’aglio, 1987, Diabetologia.

Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress.

N. Pellegrini, D. Ardigò, F. Brighenti, 2008, The American journal of clinical nutrition.

Dietary glycemic index and liver steatosis 1 – 3

N. Pellegrini, D. Ardigò, L. Monti, 2006 .

Decreased hepatic insulin extraction in subjects with mild glucose intolerance.

E. Bonora, I. Zavaroni, C. Coscelli, 1983, Metabolism: clinical and experimental.

Effects of chronic elevation of atrial natriuretic peptide and free fatty acid levels in the induction of type 2 diabetes mellitus and insulin resistance in patients with mitral valve disease.

O. Alfieri, L. Monti, P. Piatti, 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Fractional hepatic extraction of insulin in man: is it constant?

E. Bonora, I. Zavaroni, V. Manicardi, 1987, Journal of endocrinological investigation.

Further evidence that insulin metabolism is a major determinant of peripheral insulin response to oral glucose in subjects with mild glucose intolerance

E. Bonora, I. Zavaroni, V. Manicardi, 1986, Journal of endocrinological investigation.

Effectiveness of treat-to-target strategy for LDL-cholesterol control in type 2 diabetes: post-hoc analysis of data from the MIND.IT study

M. Boemi, D. Ardigò, M. Trovati, 2014, European journal of preventive cardiology.

Influence of the menstrual cycle on glucose tolerance and insulin secretion.

A. Pezzarossa, E. Bonora, E. Dall’aglio, 1987, American journal of obstetrics and gynecology.

Renal metabolism of C-peptide in man.

E. Bonora, G. Deferrari, E. Dall’aglio, 1987, The Journal of clinical endocrinology and metabolism.

Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance.

E. Bonora, G. Reaven, M. Passeri, 1987, The American journal of medicine.

in Clinical Practice of a Multifactorial Intervention for the Reduction of Cardiovascular Risk in Patients With Type 2 Diabetes The 2-year interim analysis of the MIND.IT study: a cluster randomized trial

M. Boemi, D. Ardigò, M. Trovati, 2013 .

Ability of a high-total antioxidant capacity diet to increase stool weight and bowel antioxidant status in human subjects

N. Pellegrini, C. Pellacani, F. Brighenti, 2010, British Journal of Nutrition.

Inhibition of carbohydrate-induced hypertriglyceridemia by metformin.

E. Dall’aglio, I. Zavaroni, O. Alpi, 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Cigarette smokers are relatively glucose intolerant, hyperinsulinemic and dyslipidemic.

G. Reaven, M. Passeri, E. Dall’aglio, 1994, The American journal of cardiology.

Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population

G. Reaven, E. Dall’aglio, I. Zavaroni, 1996, Journal of internal medicine.

Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care

M. Boemi, E. Bonora, A. Avogaro, 2021, Journal of Endocrinological Investigation.

Transcriptomic Analysis of Human Polarized Macrophages: More than One Role of Alternative Activation?

B. Montanini, D. Ardigò, R. Bonadonna, 2015, PloS one.

Macrophage polarization: the answer to the diet/inflammation conundrum?

D. Ardigò, F. Brighenti, D. Del Rio, 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

What is the contribution of differences in three measures of tumor necrosis factor-alpha activity to insulin resistance in healthy volunteers?

L. N. Valenti, G. Reaven, D. Ardigò, 2003, Metabolism: clinical and experimental.

Can weight gain in healthy, nonobese volunteers be predicted by differences in baseline plasma insulin concentration?

G. Reaven, I. Zavaroni, P. Massironi, 1998, The Journal of clinical endocrinology and metabolism.

Claimed effects, outcome variables and methods of measurement for health claims proposed under regulation (EC) 1924/2006 and related to cognitive function in adults.

G. Bedogni, M. Vitale, G. Passeri, 2018, Archives italiennes de biologie.

Plasma nitric oxide concentrations are elevated in insulin-resistant healthy subjects.

G. Reaven, D. Ardigò, L. Monti, 2000, Metabolism: clinical and experimental.

Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension.

G. Reaven, D. Ardigò, L. Monti, 2006, NMCD. Nutrition Metabolism and Cardiovascular Diseases.

Association between salt sensitivity and insulin concentrations in patients with hypertension.

G. Reaven, I. Zavaroni, P. Coruzzi, 1995, American journal of hypertension.

[Recommendations for cardiovascular assessment and risk reduction in diabetes--1999. Società Italiana di Diabetologia, the Diabetes and Atherosclerosis Study Group, Associazione Medici Diabetologi].

D. Cucinotta, M. Boemi, E. Manzato, 1999, Cardiologia.

Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance

M. Metra, L. Gnudi, I. Zavaroni, 2012, PloS one.

Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitor.

G. Reaven, I. Zavaroni, 1981, Metabolism: clinical and experimental.

Ability of exercise to inhibit carbohydrate-induced hypertriglyceridemia in rats.

G. Reaven, I. Zavaroni, C. Mondon, 1981, Metabolism: clinical and experimental.

High Plasma Insulin and Triglyceride Concentrations and Blood Pressure in Offspring of People with Impaired Glucose Tolerance

M. Passeri, I. Zavaroni, L. Luchetti, 1990, Diabetic medicine : a journal of the British Diabetic Association.

Studies of the mechanism of fructose-induced hypertriglyceridemia in the rat.

G. Reaven, I. Zavaroni, Y. D. Chen, 1982, Metabolism: clinical and experimental.

Do coronary heart disease risk factors change over time?

G. Reaven, D. Ardigò, I. Zavaroni, 2002, Metabolism: clinical and experimental.

Comparison of fasting plasma leptin concentrations in healthy subjects with high and low plasma insulin.

G. Reaven, I. Zavaroni, R. Delsignore, 2000, Metabolism: clinical and experimental.

Effect of fructose feeding on insulin secretion and insulin action in the rat.

G. Reaven, I. Zavaroni, S. Sander, 1980, Metabolism: clinical and experimental.

Mechanism of insulin resistance in fructose-fed rats.

G. Reaven, I. Zavaroni, C. Mondon, 1982, Metabolism: clinical and experimental.

Alterations in nitric oxide/cyclic-GMP pathway in nondiabetic siblings of patients with type 2 diabetes.

G. Reaven, L. Monti, A. Pontiroli, 2000, The Journal of clinical endocrinology and metabolism.

Comparison of the metabolic changes in rats with hypertension secondary to fructose feeding or renal artery stenosis.

G. Reaven, G. Olivetti, E. Dall’aglio, 1995, American journal of hypertension.

Relationship between plasma nitric oxide concentration and insulin resistance in essential hypertension.

G. Reaven, D. Ardigò, L. Monti, 2004, American journal of hypertension.

The increase in plasma PAI-1 associated with insulin resistance may be mediated by the presence of hepatic steatosis.

G. Reaven, D. Ardigò, L. Monti, 2010, Atherosclerosis.

Effects of naringenin and its phase II metabolites on in vitro human macrophage gene expression

L. Calani, F. Brighenti, D. Del Rio, 2013, International journal of food sciences and nutrition.

Abnormalities of insulin and lipid metabolism in Milan hypertensive rats.

G. Reaven, M. Passeri, E. Dall’aglio, 1991, American journal of hypertension.

Prevalence of hyperinsulinaemia in patients with high blood pressure

G. Reaven, M. Passeri, E. Dall’aglio, 1992, Journal of internal medicine.

Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?

A. Pezzarossa, E. Bonora, E. Dall’aglio, 1984, The Journal of clinical endocrinology and metabolism.

Insulin release in hyperuricemic patients

I. Zavaroni, C. Coscelli, U. Butturini, 2007, Acta diabetologia latina.

Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome

G. Marchesini, B. Capaldo, I. Zavaroni, 2008, Journal of endocrinological investigation.

Quercetin-3-O-glucuronide affects the gene expression profile of M1 and M2a human macrophages exhibiting anti-inflammatory effects.

D. Ardigò, A. Crozier, F. Brighenti, 2012, Food & function.

Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride.

A. Pezzarossa, E. Bonora, E. Dall’aglio, 1985, Atherosclerosis.

Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study

R. Bonadonna, I. Zavaroni, S. Haddoub, 2016, Acta Diabetologica.

Can weight gain in healthy, nonobese volunteers be predicted by differences in baseline plasma insulin concentration?

G. Reaven, I. Zavaroni, P. Massironi, 1998, The Journal of clinical endocrinology and metabolism.

Claimed effects , outcome variables and methods of measurement for health claims on foods 1 proposed under European Community Regulation 1924 / 2006 in the area of oral health

G. Bedogni, D. Angelino, G. Passeri, 2021 .

Evidence for unimpaired pancreatic secretion and hepatic removal of insulin in healthy offspring of type 2 (noninsulin-dependent) diabetic couples.

A. Pezzarossa, E. Bonora, E. Dall’aglio, 1984, Hormone research.

Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia

E. Bonora, G. Reaven, M. Passeri, 1993, Journal of internal medicine.

Renal metabolism of C peptide in type I (insulin-dependent) diabetic patients.

G. Deferrari, I. Zavaroni, C. Robaudo, 1991, The Journal of diabetic complications.

Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy young adults.

M. Metra, D. Ardigò, L. Monti, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Stearic acid at physiologic concentrations induces in vitro lipotoxicity in circulating angiogenic cells.

M. Cnop, R. Bonadonna, I. Zavaroni, 2017, Atherosclerosis.

Relationship between leptin, insulin, body composition and liver steatosis in non-diabetic moderate drinkers with normal transaminase levels.

D. Ardigò, L. Monti, P. Piatti, 2005, European journal of endocrinology.

Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.

D. Ardigò, M. Trovati, I. Zavaroni, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Development and Validation of a Food Frequency Questionnaire for the Assessment of Dietary Total Antioxidant Capacity 1,2

G. Bedogni, N. Pellegrini, V. Krogh, 2006 .

Endogenous hypertriglyceridemia in a nonobese rat model: plasma lipoproteins and dietary sensitivity.

G. Franceschini, C. Sirtori, E. Dall’aglio, 1986, Metabolism: clinical and experimental.

Insulin and hypertension: a subset analysis.

I. Zavaroni, 1996, Blood pressure. Supplement.

Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes

R. Bonadonna, I. Zavaroni, A. Dei Cas, 2017, Cardiovascular Diabetology.

GP/EFSA/NUTRI/2014/01 Scientific substantiation of health claims made on food: collection, collation and critical analysis of information in relation to claimed effects, outcome variables and methods of measurement

G. Bedogni, M. Vitale, G. Passeri, 2018 .

N-3 PUFA increase bioavailability and function of endothelial progenitor cells.

R. Raddino, L. Gnudi, M. Goldoni, 2014, Food & function.

Reduced Circulating Endothelial Progenitor Cell Number in Young Adult Hyperinsulinemic Healthy Men

D. Ardigò, L. Monti, L. Gnudi, 2010 .

Secretion and hepatic removal of insulin in the healthy offspring of type 2 (non-insulin-dependent) diabetic subjects.

A. Pezzarossa, E. Bonora, E. Dall’aglio, 1984, Diabete & metabolisme.

Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations?

M. Boemi, M. Trovati, I. Zavaroni, 2008, European Journal of Clinical Nutrition.

Dietary glycemic index and liver steatosis.

N. Pellegrini, D. Ardigò, L. Monti, 2006, The American journal of clinical nutrition.

Erratum: Development and validation of a food frequency questionnaire for the assessment of dietary total antioxidant capacity (Journal of Nutrition (2007) 137, (93-98))

G. Bedogni, N. Pellegrini, V. Krogh, 2007 .

The total antioxidant capacity of the diet is an independent predictor of plasma beta-carotene.

N. Pellegrini, D. Ardigò, P. Riso, 2007, European journal of clinical nutrition.

Claimed effects, outcome variables and methods of measurement for health claims proposed under Regulation (EC) 1924/2006 in the framework of bone health

G. Bedogni, M. Vitale, D. Angelino, 2018 .

Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under Regulation (EC) 1924/2006 in the area of oral health

G. Bedogni, M. Vitale, D. Angelino, 2018 .

Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population.

N. Pellegrini, D. Ardigò, F. Brighenti, 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study

R. Bonadonna, I. Zavaroni, A. Dei Cas, 2017, International journal of molecular sciences.

Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health.

G. Bedogni, M. Vitale, G. Passeri, 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Association of Insulin Resistance, Hyperleptinemia, and Impaired Nitric Oxide Release With In-Stent Restenosis in Patients Undergoing Coronary Stenting

C. Di Mario, A. Colombo, A. Caumo, 2003, Circulation.

Habitual leisure‐time physical activity is associated with differences in various risk factors for coronary artery disease

E. Bonora, G. Reaven, M. Passeri, 1989, Journal of internal medicine.

Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims Proposed Under European Community Regulation 1924/2006 in the Framework of Maintenance of Skin Function

G. Bedogni, M. Vitale, D. Angelino, 2017, Nutrients.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy.

M. Boemi, D. Ardigò, M. Trovati, 2008, Atherosclerosis.

ADMA is independently related to flow‐mediated vasodilation in subjects at low cardiovascular risk

G. Reaven, D. Ardigò, O. Pachinger, 2007, European journal of clinical investigation.

Relation of plasma insulin levels to forearm flow-mediated dilatation in healthy volunteers.

G. Reaven, D. Ardigò, L. Monti, 2006, The American journal of cardiology.

Development and validation of a food frequency questionnaire for the assessment of dietary total antioxidant capacity.

G. Bedogni, N. Pellegrini, V. Krogh, 2007, The Journal of nutrition.

Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes

M. Boemi, E. Bonora, A. Avogaro, 2021, Cardiovascular Diabetology.

Claimed effects, outcome variables and methods of measurement for health claims on foods related to the gastrointestinal tract proposed under regulation (EC) 1924/2006

G. Bedogni, M. Vitale, D. Angelino, 2018, International journal of food sciences and nutrition.

Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited.

G. Reaven, E. Dall’aglio, I. Zavaroni, 1999, Metabolism: clinical and experimental.

Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects

Corrado Priami, Luca Marchetti, Diego Ardigò, 2017, PloS one.

Effects of TiO2 and Co3O4 Nanoparticles on Circulating Angiogenic Cells

G. Passeri, R. Bonadonna, M. Goldoni, 2015, PloS one.

Dietary antioxidants and glucose metabolism

D. Ardigò, I. Zavaroni, L. Franzini, 2008, Current opinion in clinical nutrition and metabolic care.

Changes in blood pressure, plasma triglyceride and aldosterone concentration, and red cell cation concentration in patients with hyperinsulinemia.

G. Reaven, R. Pontremoli, I. Zavaroni, 1991, American Journal of Hypertension.

Advanced diagnostic support in lipidology project: role for phenotypic and functional evaluation of lipoproteins in dyslipidemias

D. Ardigò, E. Favari, F. Zimetti, 2010 .

[Chronic heart failure and cachexia: role of endocrine system].

I. Zavaroni, A. Dei Cas, A. Muoio, 2011, Minerva cardioangiologica.

Reduced circulating endothelial progenitor cell number in healthy young adult hyperinsulinemic men.

D. Ardigò, L. Monti, L. Gnudi, 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Hyperinsulinaemia, obesity, and syndrome X

M. Fantuzzi, G. Reaven, M. Passeri, 1994, Journal of internal medicine.

Effect of Age and Environmental Factors on Glucose Tolerance and Insulin Secretion in a Worker Population

A. Pezzarossa, E. Bonora, E. Dall’aglio, 1986, Journal of the American Geriatrics Society.

Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under European Community Regulation 1924/2006 in the area of appetite ratings and weight management

G. Bedogni, M. Vitale, G. Passeri, 2018, International journal of food sciences and nutrition.

Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims on Foods Related to Vision Proposed Under Regulation (EC) 1924/2006

G. Bedogni, M. Vitale, D. Angelino, 2018, Nutrients.

A performance score of the quality of inpatient diabetes care is a marker of clinical outcomes and suggests a cause‐effect relationship between hypoglycaemia and the risk of in‐hospital mortality

R. Bonadonna, I. Zavaroni, A. Sforza, 2020, Diabetes/metabolism research and reviews.

Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the area of blood glucose and insulin concentrations

G. Bedogni, M. Vitale, G. Passeri, 2018, Acta Diabetologica.

Glucose- and Lipid-Related Biomarkers Are Affected in Healthy Obese or Hyperglycemic Adults Consuming a Whole-Grain Pasta Enriched in Prebiotics and Probiotics: A 12-Week Randomized Controlled Trial.

N. Pellegrini, D. Angelino, P. Vitaglione, 2019, The Journal of nutrition.

Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations.

G. Reaven, D. Ardigò, L. Monti, 2005, Metabolism: clinical and experimental.

Relationships between insulin secretion, insulin metabolism and insulin resistance in mild glucose intolerance.

E. Bonora, I. Zavaroni, V. Manicardi, 1987, Diabete & metabolisme.

Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects.

C. Zancanaro, E. Bonora, I. Zavaroni, 1984, Current medical research and opinion.

Multivariate Prediction of Subcutaneous Glucose Concentration in Type 1 Diabetes Patients Based on Support Vector Regression

Dimitrios I. Fotiadis, Eleni I. Georga, Vasilios C. Protopappas, 2013, IEEE Journal of Biomedical and Health Informatics.

Clinically driven semi-supervised class discovery in gene expression data

Israel Steinfeld, Roy Navon, Zohar Yakhini, 2008, ECCB.

Insulin-resistance and associated risk factors for coronary heart disease as seen in families.

G. Reaven, I. Zavaroni, 1991, Diabete & metabolisme.

Pulmonary complications in diabetes mellitus: the role of glycemic control.

D. Ardigò, I. Zavaroni, R. Delsignore, 2004, Current drug targets. Inflammation and allergy.

Hyperinsulinemia and impaired leptin-adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in subjects with in-stent restenosis.

O. Alfieri, G. Reaven, L. Citterio, 2008, American journal of physiology. Endocrinology and metabolism.

C-Peptide to Insulin Molar Ratios at Fasting and after Oral Glucose in 247 Healthy Subjects

A. Pezzarossa, E. Bonora, E. Dall’aglio, 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

HLA antigens and insulin dependent diabetes mellitus. A family study.

I. Zavaroni, M. Savi, T. Neri, 1977, Diabete & metabolisme.

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity.

M. Boemi, E. Bonora, A. Avogaro, 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.

D. Ardigò, M. Trovati, I. Zavaroni, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.